Nanotein Technologies Store

Best-in-Class solutions for Cell Expansion Reagents

Expand and activate CAR-T cells, targeting CD8+ expansion for high stemness and therapy efficacy
Robust activation and expansion with more control over the ratio between CD8+ and CD4+ T cells
Feeder free, high quality NK cell activation and expansion for NK cell therapy programs
  • NanoSpark™ STEM-T
    Soluble T Cell Activator

    The NanoSparkTM STEM-T Soluble T Cell Activator reagent kit is an easy-to-use T cell activator for T cell expansion, including CAR-T cells.
    • Soluble format
    • All protein-based
    • No magnetic components
    • High total & stemlike CD8+ T cell production
    • Anti-CD3/CD28 based
    • GMP in production, available ~Q1 2024

    Add NanoSparkTM STEM-T Soluble T Cell Activator to your cart now!

    Part Number: STEM-T

    $275.00

    Learn More
  • NanoSpark™ EVEN-T
    Soluble T Cell Activator

    The NanoSparkTM EVEN-T Soluble T Cell Activator reagent kit allows the user to modulate the CD4+:CD8+ ratio in a dose-dependent manner during T cell expansion, including CAR-T cells.
    • First-in-Class CD4+:CD8+ ratio shifting technology
    • Soluble format
    • All protein-based
    • No magnetic components
    • Anti-CD3/CD28 based
    • GMP in production, available ~Q2/Q3 2024

    Add NanoSparkTM EVEN-T Soluble T Cell Activator to your cart now!

    Part Number: EVEN-T

    $300.00

    Learn More
  • NanoSpark™ GROW-NK
    Soluble NK Cell Activator

    The NanoSparkTM GROW-NK Soluble Activator uses anti-NKp46 & anti-CD2 mAbs on the NanoSparkTM platform to activate and expand NK cells in an easy-to-use, feeder-free manner.
    • High performance
    • Feeder-free
    • Soluble, all protein-based
    • No magnetic components

    Add NanoSparkTM GROW-NK Soluble Activator to your cart now!

    Part Number: GROW-NK

    $325.00

    Learn More

Nanotein Technologies Store

More Effective Cell Therapies, Faster

Highly Efficient

Our technology is able to produce larger quantities of T cells in less time than competitor reagents.

Improved Outcomes

Clinical and preclinical research has shown enhanced tumor destruction and sustained disease remission, when CAR-T therapies are enriched for Tscm’s, a T-cell subtype, Nanotein’s product excels at expanding.

Lower Risk

We use protein-based components in our manufacturing, eliminating the risk of synthetic or magnetic contaminants.

Nanotein Technologies Store

Best-in-Class solutions for Cell Expansion Reagents